Navigation Links
PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
Date:9/24/2008

results of the studies relating to human safety and possible adverse effects resulting from the administration of the Company's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the Company's development programs, the award of government contracts to our competitors, unforeseen safety issues, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Form 10-K under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC"). In particular, the studies described above involving Protexia(R) and Valortim(R) constitute non-clinical animal studies. Significant additional non-clinical animal studies, human clinical trials, and manufacturing development work remain to be done under both programs. At this point there can be no assurance that either of these product candidates will be shown to be safe and effective and approved by regulatory authorities for use in humans. Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at http://www.pharmathene.com.


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
2. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
5. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
11. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... -- Nitrosolution.com, a website that features safe and all-natural ... anniversary in August. The online retailer specializes in an ... ability to produce nitric oxide. Called Nitroxyl, it is ... variety of phytonutrients and other natural ingredients that a ... nitric oxide production in the arteries and brain. ...
(Date:7/21/2014)... , July 21, 2014 Thoratec Corporation ... device-based mechanical circulatory support therapies to save, support and ... its operating results for the second quarter of fiscal ... company will hold a conference call to discuss its ... parties, at 1:30 p.m., Pacific Daylight Time (4:30 p.m., ...
(Date:7/21/2014)... , July 21, 2014  EHE International, the recognized ... a nationwide physician network, today announced that Dignity Health ... NV has been named an EHE-certified preventive ... Las Vegas region now have greater ... maintain their health. "EHE is proud ...
Breaking Medicine Technology:Up and Coming Nitric Oxide Supplements Company Nitrosolution.com Celebrates its One Year Anniversary 2Thoratec Schedules Second Quarter Conference Call, Webcast 2EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2
(Date:7/21/2014)... On Monday, September 22, 2014 Push to Walk ... McGuriman-Motorola Solutions at The Knoll West Country Club, Knoll & ... lunch at 11 a.m. The price of $225 includes ... to $250 after September 7th. Non-golfers and guests are ... The dinner will include a special silent and live auction ...
(Date:7/21/2014)... PowerObjects, a professional services firm 100% ... for Microsoft Dynamics CRM, has joined the prestigious ... of the most strategic Microsoft Dynamics partners from ... them in the highest echelon of the Microsoft ... Microsoft Dynamics Inner Circle have performed to a ...
(Date:7/21/2014)... to hate losing. , Unfortunately, it,s also human ... solid strategy and thus increasing your chances of losing ... a Brigham Young University study published this week by ... based on an analysis of two decades of data ... whether coaches adjusted their personnel following games where the ...
(Date:7/21/2014)... Chicago, July 20, 2014The Associated Press-NORC Center for Public ... survey examining the public,s opinions about what it means ... United States. The survey, funded by the Robert Wood ... perceive the quality of their health care and doctors, ... when making health care decisions. The survey produces new ...
(Date:7/21/2014)... 2014 (HealthDay News) -- A recently developed molecular tool allowed ... lab. The team of scientists at Temple University School ... lead to a permanent treatment for HIV. They added that ... to offer protection against the disease in the future. ... of the virus is required in order to cure the ...
Breaking Medicine News(10 mins):Health News:7th Annual Push to Walk Golf Outing to Be Held September 22nd 2Health News:PowerObjects Joins the 2014 Microsoft Dynamics Inner Circle 2Health News:'Moral victories' might spare you from losing again 2Health News:National survey from AP-NORC examines perceptions of health care provider quality 2Health News:Scientists Snipped HIV Out of Human DNA 2
... By Amanda Gardner HealthDay Reporter , TUESDAY, May ... preliminary, genetic test that seems to predict which breast cancer ... in turn, could greatly help guide treatment, according to a ... of the American Medical Association . The findings are ...
... , TUESDAY, May 10 (HealthDay News) -- Shortages of anesthetics ... of a new survey. The findings revealed that more ... 1,350 from the United States) are experiencing a shortage of ... percent of the respondents encountered a similar problem, the poll ...
... 10 (HealthDay News) -- Many tanning salons in the United ... cancer risks posed by tanning beds, according to a new ... more than 3,800 white females aged 14 to 22 from ... attitudes and behavior. The survey found that 43 percent ...
... About 14 percent of strokes happen while people are sleeping, ... the hospital in time for a potentially brain-saving treatment, a ... ischemic stroke must be given within a few hours after ... symptoms often can,t receive the treatment since we can,t determine ...
... the disturbing act of self-injury is nothing new to ... identified a more severe type of behavior that is ... and under-reported, Self-Embedding Behavior (SEB) is a form of ... tissue either under the skin or into muscle. ...
... the prevalence of overall cardiovascular risk in the Spanish working ... risk (8% on men and 2% in women). This prevalence ... the farming sector, followed by construction, industry and services. ... level of cardiovascular risk, but only a minority of these ...
Cached Medicine News:Health News:Genetic Test Shows Promise in Guiding Breast Cancer Care 2Health News:Genetic Test Shows Promise in Guiding Breast Cancer Care 3Health News:Shortage of Anesthetics Reported 2Health News:Too Few Teens Know the Dangers of Tanning Beds: Poll 2Health News:Research Suggests 1 in 7 Strokes Happens During Sleep 2Health News:A new study on self-injury behavior encourages quick and targeted intervention 2Health News:6 percent of Spanish workers have high cardiovascular risk 2
... most energy efficient refrigerator on the market ... throughout the unit. The contoured drain channels ... steel outer walls are coated with a ... textured steel door is reversible. The interior ...
... The F340 is a basic laboratory system ... pH results can be obtained when used ... 3-in-1 electrode. • Fast and easy one ... recognition for five buffers (pH 1.68, 4.00, ...
... The F340 is a basic laboratory system ... pH results can be obtained when used ... 3-in-1 electrode. • Fast and easy one ... recognition for five buffers (pH 1.68, 4.00, ...
... The F340 is a basic laboratory system ... pH results can be obtained when used ... 3-in-1 electrode. • Fast and easy one ... recognition for five buffers (pH 1.68, 4.00, ...
Medicine Products: